Holen Sie sich die Stockscreener-App
13.04
1.58%
-0.21
Handel nachbörslich:
13.04
Schlusskurs vom Vortag:
$13.25
Offen:
$13.235
24-Stunden-Volumen:
54.31M
Relative Volume:
0.78
Marktkapitalisierung:
$6.80B
Einnahmen:
$1.61B
Nettoeinkommen (Verlust:
$282.33M
KGV:
24.97
EPS:
0.5223
Netto-Cashflow:
$352.16M
1W Leistung:
-4.33%
1M Leistung:
-20.44%
6M Leistung:
+7.50%
1J Leistung:
+4.07%
1-Tages-Spanne:
$12.65
$13.37
1-Wochen-Bereich:
$12.65
$14.04
52-Wochen-Spanne:
$9.2002
$19.84
Uipath Inc Stock (PATH) Company Profile
Firmenname
Uipath Inc
Sektor
Branche
Telefon
(844) 432-0455
Adresse
ONE VANDERBILT AVENUE, NEW YORK
Compare PATH vs MSFT, PLTR, ORCL, CRWD, FTNT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PATH
Uipath Inc
|
13.04 | 6.91B | 1.61B | 282.33M | 352.16M | 0.5223 |
MSFT
Microsoft Corp
|
500.59 | 3.70T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
191.79 | 444.54B | 5.22B | 2.29B | 2.69B | 0.8876 |
ORCL
Oracle Corp
|
144.56 | 451.14B | 67.36B | 17.31B | -23.69B | 5.8248 |
CRWD
Crowdstrike Holdings Inc
|
262.49 | 256.05B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
178.74 | 127.86B | 7.11B | 1.95B | 2.44B | 2.5883 |
Uipath Inc Stock (PATH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Needham | Hold → Buy |
| 2025-10-02 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-09-05 | Fortgesetzt | DA Davidson | Neutral |
| 2025-03-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-12 | Eingeleitet | UBS | Sell |
| 2024-06-03 | Herabstufung | Macquarie | Outperform → Neutral |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-05-30 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-30 | Herabstufung | Truist | Buy → Hold |
| 2024-05-30 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-04-08 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-03-14 | Bestätigt | Needham | Buy |
| 2024-02-21 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-01-02 | Eingeleitet | William Blair | Outperform |
| 2023-06-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-04-21 | Eingeleitet | DA Davidson | Neutral |
| 2023-03-16 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-11-03 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-10-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-09-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-01-25 | Hochstufung | Macquarie | Neutral → Outperform |
| 2022-01-20 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-06 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-12-09 | Hochstufung | Berenberg | Hold → Buy |
| 2021-12-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-09-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-12 | Eingeleitet | Summit Insights | Sell |
| 2021-05-17 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-05-17 | Eingeleitet | Barclays | Equal Weight |
| 2021-05-17 | Eingeleitet | BofA Securities | Buy |
| 2021-05-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-05-17 | Eingeleitet | Cowen | Outperform |
| 2021-05-17 | Eingeleitet | DA Davidson | Buy |
| 2021-05-17 | Eingeleitet | Evercore ISI | In-line |
| 2021-05-17 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-17 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2021-05-17 | Eingeleitet | Macquarie | Neutral |
| 2021-05-17 | Eingeleitet | Mizuho | Buy |
| 2021-05-17 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-17 | Eingeleitet | Needham | Buy |
| 2021-05-17 | Eingeleitet | Oppenheimer | Perform |
| 2021-05-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-05-17 | Eingeleitet | Truist | Buy |
| 2021-05-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-05-17 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-05-13 | Eingeleitet | Berenberg | Hold |
Alle ansehen
Uipath Inc Aktie (PATH) Neueste Nachrichten
Truist Trims UiPath Target After Investor Day Skips New Goals - GuruFocus
'LLMs don't learn': Dines launches UiPath Cartographer - The Next Web
Genzeon Named UiPath 2026 Industry Impact Partner of the Year for Healthcare and Life Sciences - PR Newswire
UiPath Stock Falls as Analyst Highlights Expanding AI Opportunity - Benzinga
Truist Securities maintains Hold rating on UiPath, $14 price target - TradingView
UiPath, Inc. Announces New And Planned Enhancements To UiPath Test Cloud - marketscreener.com
UiPath's Transition to Business Orchestration, Automation Technologies Remains 'Show-Me Story,' RBC Says - marketscreener.com
TD Cowen Reaffirms Hold Rating for UiPath (NYSE:PATH) - MarketBeat
UiPath Inc (Derivatives) to Canadian Dollar Price Today | Live PATH to CAD Converter & Exchange Rate - CryptoRank
Truist cuts UiPath stock price target to $14 on sector volatility - Investing.com Canada
UiPath stock price target cut to $15 by UBS on FY28 outlook - Investing.com Canada
RBC Capital cuts UiPath stock price target on execution concerns By Investing.com - Investing.com Canada
UBS Adjusts UiPath Price Target to $15 From $19, Maintains Neutral Rating - marketscreener.com
RBC Capital cuts UiPath stock price target on execution concerns - Investing.com
UiPath Expands Test Cloud With Autonomous Testing Features - marketscreener.com
UBS Group Has Lowered Expectations for UiPath (NYSE:PATH) Stock Price - MarketBeat
UiPath announces new AI upgrades: Will PATH stock rebound now? - TradingView
RBC Cuts Price Target on UiPath to $15 From $17, Keeps Sector Perform Rating - marketscreener.com
RBC Capital maintains Sector Perform rating on UiPath, $15 price target - TradingView
Ashling Recognized as a UiPath 2026 Partner of the Year Award Winner - Yahoo Finance
Truist Cuts Price Target on UiPath to $14 From $17, Keeps Hold Rating - marketscreener.com
Needham reiterates UiPath stock buy rating on AI automation focus By Investing.com - Investing.com Canada
UiPath announces platform updates for enterprise automation By Investing.com - Investing.com Canada
UiPath announces AI-powered testing enhancements for Test Cloud By Investing.com - Investing.com Canada
UiPath Honors 2026 Partner Award Winners at its FUSION Conference - Yahoo Finance
UiPath launches Cartographer for enterprise process mapping By Investing.com - Investing.com Canada
Companies can keep UiPath's full automation platform on their own systems. - Stock Titan
UiPath Test Cloud Accelerates Autonomous Testing at Enterprise Scale - Yahoo Finance Singapore
UiPath Launches UiPath Cartographer, Helping Enterprises Turn Scattered Process Knowledge into an Actionable View of How Their Business Runs - Yahoo Finance Singapore
Needham reiterates UiPath stock buy rating on AI automation focus - Investing.com
UiPath (NYSE:PATH) Earns Buy Rating from Needham & Company LLC - MarketBeat
Needham reiterates Buy rating on UiPath, $22 price target - TradingView
Connecting the Dots on UiPath’s Investor Day: The Evolution of the Enterprise Control Plane - Moomoo
UiPath Targets $2B ARR With AI Orchestration Push at Investor Day - MarketBeat
UiPath (PATH) Could Be 39% Undervalued After PLDT Showed AI Automation Gains - simplywall.st
UiPath Inc : RBC Cuts Target Price to $15 Fro - Moomoo
(PATH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
UiPath Execs, Investor Clash Over Bid To Ax Derivative Suit - Law360
Is UiPath Stock Cheap Because Of What AI Might Do? - Yahoo Finance
UiPath, Inc. (PATH) stock price, news, quote and history - Yahoo Finance UK
UiPath's CTO Sells Over 40,000 Shares Amid a 16% One-Year Return - The Motley Fool
Why Is UiPath (NYSE:PATH) Gaining Focus in Technology Stocks? - kalkinemedia.com
UiPath's CTO Sells Over 40,000 Shares Amid a 16% One-Year Return - The Motley Fool
UiPath CPO & CTO Malpani sells $566k in stock By Investing.com - Investing.com South Africa
UiPath CPO & CTO Malpani sells $566k in stock - Investing.com
Raghavendra Malpani Sells 40,464 Shares of UiPath (NYSE:PATH) Stock - MarketBeat
UiPath (PATH) CPO & CTO sells 40K shares in planned trade - Stock Titan
UiPath Inc (Derivatives) to Russian Ruble Price Today | Live PATH to RUB Converter & Exchange Rate - CryptoRank
UiPath Inc (Derivatives) to Vietnamese Dong Price Today | Live PATH to VND Converter & Exchange Rate - CryptoRank
UiPath Inc (Derivatives) to Euro Price Today | Live PATH to EUR Converter & Exchange Rate - CryptoRank
UiPath Inc (Derivatives) Analytics: Price Dynamics, Quarterly Returns, and Annual Price Changes in USD - CryptoRank
Finanzdaten der Uipath Inc-Aktie (PATH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.68%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):